0001209191-22-005659.txt : 20220131 0001209191-22-005659.hdr.sgml : 20220131 20220131171632 ACCESSION NUMBER: 0001209191-22-005659 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220127 FILED AS OF DATE: 20220131 DATE AS OF CHANGE: 20220131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lavelle Erin CENTRAL INDEX KEY: 0001737613 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40708 FILM NUMBER: 22575063 MAIL ADDRESS: STREET 1: C/O ALDER BIOPHARMACEUTICALS, INC. STREET 2: 11804 NORTH CREEK PARKWAY SOUTH CITY: BOTHELL STATE: WA ZIP: 98011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eliem Therapeutics, Inc. CENTRAL INDEX KEY: 0001768446 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 832273741 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 23515 NE NOVELTY HILL ROAD STREET 2: SUITE B221 #125 CITY: REDMOND STATE: WA ZIP: 98053 BUSINESS PHONE: 425-276-2300 MAIL ADDRESS: STREET 1: 23515 NE NOVELTY HILL ROAD STREET 2: SUITE B221 #125 CITY: REDMOND STATE: WA ZIP: 98053 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-27 0 0001768446 Eliem Therapeutics, Inc. ELYM 0001737613 Lavelle Erin C/O ELIEM THERAPEUTICS, INC. 23515 NE NOVELTY HILL RD, STE. B221 #125 REDMOND WA 98053 0 1 0 0 COO & CFO Stock Option (Right to Buy) 8.21 2022-01-27 4 A 0 170000 0.00 A 2032-01-26 Common Stock 170000 170000 D For so long as the Reporting Person continuously provides services to the Issuer, this option will vest with respect to the shares as follows: 1/48th of the shares will vest on each monthly anniversary of January 27, 2022. /s/ Alan Hambelton, Attorney-in-Fact 2022-01-31